The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Cognitive decline in Parkinson disease
Open accessAbstract
Dementia is a frequent problem encountered in advanced stages of Parkinson disease (PD). In recent years, research has focused on the pre-dementia stages of cognitive impairment in PD, including mild cognitive impairment (MCI). Several longitudinal studies have shown that MCI is a harbinger of dementia in PD, although the course is variable, and stabilization of cognition - or even reversal to normal cognition - is not uncommon. In addition to limbic and cortical spread of Lewy pathology, several other mechanisms are likely to contribute to cognitive decline in PD, and a variety of biomarker studies, some using novel structural and functional imaging techniques, have documented in vivo brain changes associated with cognitive impairment. The evidence consistently suggests that low cerebrospinal fluid levels of amyloid-β 42, a marker of comorbid Alzheimer disease (AD), predict future cognitive decline and dementia in PD. Emerging genetic evidence indicates that in addition to the APOE*ε4 allele (an established risk factor for AD), GBA mutations and SCNA mutations and triplications are associated with cognitive decline in PD, whereas the findings are mixed for MAPT polymorphisms. Cognitive enhancing medications have some effect in PD dementia, but no convincing evidence that progression from MCI to dementia can be delayed or prevented is available, although cognitive training has shown promising results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover there are several candidate genetic risk factors that overlap for AD and PD, most notably APOE and MAPT [127].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
Self-citationLitvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., Mollenhauer, B., Adler, C. H., Marder, K., Williams‐Gray, C. H., et al. (2012) · Movement Disorders · doi:10.1002/mds.24893 · Cited by 2,609
Self-citationThe Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., ADENA, M. A., Halliday, G. M., & Morris, J. G. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,346
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Prevalence and Characteristics of Dementia in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403
Self-citationMultimodal classification of Alzheimer's disease and mild cognitive impairment
Zhang, D., Wang, Y., Zhou, L., Yuan, H., & Shen, D. G. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.008 · Cited by 1,340
Cited by
Sorted by citations
Items 801–900 of 1,000
Cognitive dysfunction in Parkinson's disease: Hippocampal vulnerability and redox-driven mechanisms.
Curto, A. R., Silva, A. A., Fiadeiro, M. B., Pereira, D., & Cristóvão, A. C. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104318 · Cited by 1
Troubles cognitifs légers et maladie de Parkinson
Fénelon, G., & Salhi, H. S. (2018) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2018.08.003 · Cited by 1
Swank, C., & Criminger, C. (2019) · Physiotherapy Practice and Research · doi:10.3233/ppr-190146 · Cited by 1
Xu, S., Zhang, Y., Xiao, G., Duan, Y., Wang, M., Song, Y., Dai, Y., Liu, J., Luo, J., Zhang, S., et al. (2020) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc44109.2020.9175452 · Cited by 1
Su, K., Liu, S., Yuan, J., Li, J., Li, R., & Feng, X. (2020) · Medicine · doi:10.1097/md.0000000000022021 · Cited by 1
Neuropathological features of cognitive decline in Lewy body dementia
Sengoku, R. (2020) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12444 · Cited by 1
Kisvetrová, H. (2020) · doi:10.5507/fzv.20.24457772 · Cited by 1
Fearing Parkinson’s Disease: Relationships Between Cognition and Emotion
Herrera, M. L., Champarini, L. G., Otamendi, A., & Hereñú, C. B. (2021) · Springer eBooks · doi:10.1007/978-3-030-61721-9_30 · Cited by 1
CHANGES IN THE MICROSTRUCTURE AND FUNCTION OF BRAIN TISSUE IN PD BY DIFFUSION KURTOSIS IMAGING
Wang, L., Liu, X., Wu, S., CHEN, F., ZHENG, Y., GUO, G., XUAN, Y., & Yan, G. (2021) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s0219519421400625 · Cited by 1
Niethammer, M., & Franceschi, A. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_36 · Cited by 1
BEYİN YAŞLANMASINDA MOLEKÜLER MEKANİZMALAR
ÖZDEK, E., & Han, S. (2022) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1099963 · Cited by 1
York, M. K., & Alcalay, R. N. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105403 · Cited by 1
Sumalatha, U., Prakash, K., Prabhu, S., & Nayak, V. C. (2023) · Communications in computer and information science · doi:10.1007/978-981-99-2264-2_13 · Cited by 1
Yulian, Z. H. U., & Xi, C. (2023) · Rehabilitation Medicine · doi:10.3724/sp.j.1329.2023.02014 · Cited by 1
Performing With Parkinson’s: Leaving Traces
Pohjola, H., Sivak, E., & Åström, Å. N. (2023) · Nordic journal of dance · doi:10.2478/njd-2023-0011 · Cited by 1
Liu, C., Yuan, M., & He, S. (2023) · Brain and Behavior · doi:10.1002/brb3.3345 · Cited by 1
Goldin, C. T., Vaughan, C. L., Hoyt, B. D., & Kern, D. S. (2024) · Deep Brain Stimulation · doi:10.1016/j.jdbs.2024.03.001 · Cited by 1
Patients' Awareness of Symptoms, Understanding and Perception of Parkinson's Disease
Majid, N., Aziz, N. N. Y. N., Desa, S. H. M., & Suryanto, S. (2024) · Environment-Behaviour Proceedings Journal · doi:10.21834/e-bpj.v9i27.5656 · Cited by 1
Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson’s disease
Soares, N. M., da Silva, P. H. R., Pereira, G. M., Leoni, R. F., Rieder, C. R. D. M., & Pianoschi, T. A. (2024) · Neuroradiology · doi:10.1007/s00234-024-03452-6 · Cited by 1
Dopaminergic Treatment and Episodic Memory in Parkinson’s Disease: A Meta-analysis of the Literature
Stanzione, A., Melchiori, F. M., da Costa, A. L. C., Leonardi, C., Scalici, F., Caltagirone, C., & Carlesimo, G. A. (2024) · Neuropsychology Review · doi:10.1007/s11065-024-09656-0 · Cited by 2
Brandão, P. R. D. P., Pereira, D. A., Koshimoto, B. H. B., Borges, V., Ferraz, H. B., Schuh, A. F. S., Rieder, C. R. D. M., Olchik, M. R., Mata, I. F., Tumas, V., et al. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2020019 · Cited by 1
Díaz-Hung, M. L., Ruiz-Fuentes, J. L., Díaz-García, A., León-Martínez, R., Alberti‐Amador, E., Fuentes, N. P., & Blanco-Lezcano, L. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.09.026 · Cited by 1
Anaesthesia for Deep Brain Stimulation Surgery
Bos, M. J., Hermans, B. J. E., & Bühre, W. (2020) · Springer eBooks · doi:10.1007/978-3-030-36346-8_7 · Cited by 1
Cognitive impairment and its association with cholinergic dysfunction in Parkinson’s disease
Baba, T., & Takeda, A. (2020) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12417 · Cited by 1
Biomarker detection of Parkinson’s disease: therapy and treatment using nanomaterials
Nanda, R., Panda, P., & Mishra, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817923-9.00017-1 · Cited by 1
Walmsley, S., Chandley-Pascoe, D., Collins, E., & Marquez, J. L. (2020) · New Zealand Journal of Physiotherapy · doi:10.15619/nzjp/48.3.05 · Cited by 1
Deficits in or preservation of basic number processing in Parkinson’s disease? A registered report
Loenneker, H. D., Artemenko, C., Willmes, K., Liepelt‐Scarfone, I., & Nuerk, H. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24907 · Cited by 1
Cognitive and language deficits in persons with Parkinson's disease
Vuković, M., & Jerkić, L. (2021) · Specijalna edukacija i rehabilitacija · doi:10.5937/specedreh20-32850 · Cited by 1
McLaughlin, J., & Young, T. (2021) · BJPsych Advances · doi:10.1192/bja.2021.67 · Cited by 1
Betätigungsorientierte Therapieansätze für parkinsonspezifische Themen
Orellana, A. (2021) · Springer eBooks · doi:10.1007/978-3-662-62583-5_14 · Cited by 1
Current Research on Deep Brain Stimulation and Cognitive Impairment in Parkinson’s Disease
Shahlaie, K., Sperry, L., Wei, L., & Zhang, L. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101603 · Cited by 1
Filippi, M., & Agosta, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-66773-3_4 · Cited by 1
Neuropathological changes in advanced Parkinson’s disease
Adachi, T., & Hanajima, R. (2022) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.12596 · Cited by 2
Torriani‐Pasin, C., de Freitas, T. B., Araujo, B., Palma, G. C. S., Makhoul, M. P., Andreotti, R. A., Domingues, V. L., & Mochizuki, L. (2022) · Brazilian Journal of Motor Behavior · doi:10.20338/bjmb.v16i1.251 · Cited by 1
Botta, R., Keshav, K. J., Kutty, B. M., Mahadevan, A., Pal, P. K., & Yadav, R. (2023) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_903_22 · Cited by 1
Zhu, F., Li, F., Ling, X., Liu, Q., & Shen, B. (2019) · Research Square · doi:10.1101/2019.12.18.880997 · Cited by 1
Karunanayaka, P., Lu, J., Lewis, M. M., Elyan, R., Yang, Q. X., Eslinger, P. J., & Huang, X. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.21.427682 · Cited by 1
Moreno, A. J., Luthra, N., Bonham, L. W., Lin, J. Y., Broestl, L., Bétourné, A., Sehgal, R., Wang, D., Lesné, S., Ostrem, J. L., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-89525/v1 · Cited by 1
Chiara, S., Bon, C., Cecco, E. D., Marta, C., Narkiewicz, J., Pietro, P., Perissinotto, F., Claudio, S., Francesca, P., Giuseppe, L., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.13.464204 · Cited by 1
Garcia, P., Wemheuer, W. M., Huarte, O. U., Schmit, K. J., Masuch, A., Brioschi, S., Weihofen, A., Koncina, E., Coowar, D., Heurtaux, T., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.05.237750 · Cited by 2
Huang, M., Cai, X., Zhang, Y., Pu, W., Gao, B., & Yu, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1988963/v1 · Cited by 1
Multi-‘Omic Integration via Similarity Network Fusion to Detect Molecular Subtypes of AgingPreprint
Yang, M., Matan‐Lithwick, S. A., Wang, Y., Jager, P. L. D., Bennett, D. A., & Felsky, D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.16.516806 · Cited by 1
Pathologic subtyping of Alzheimer’s disease brain tissue reveals disease heterogeneityPreprint
Lam, T. G., Ross, S. K., Ciener, B., Xiao, H., Flaherty, D., Lee, A., Dugger, B. N., Reddy, H., & Teich, A. F. (2024) · medRxiv · doi:10.1101/2024.10.14.24315458 · Cited by 1
Theint, A. T., Cazares, N., Zhang, S., Zhang, N., Mosley, R., Ishida, K., Higuchi, M., Peng, C., & Zeiger, W. (2026) · npj Parkinson s Disease · doi:10.1101/2025.07.31.668024 · Cited by 1
Targeting the Gut-Brain axis in Parkinson's disease
Perez‐Pardo, P. (2017) · Utrecht University Repository (Utrecht University)
Longitudinal magnetic resonance imaging of cognitive impairment in Parkinson’s disease
Almuqbel, M. M. (2018) · Otago University Research Archive (University of Otago)
Cozac, V., Bogaarts, J. G., Chaturvedi, M., Gschwandtner, U., Hatz, F., Meyer, A. H., Röth, V., & Fuhr, P. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.04.708
Predicting Onset of Dementia in Parkinson's Disease PatientsPreprint
Agarwal, D., Srivastava, A., & Huang, E. W. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1906.03226
Icesi, U., Andres Navarro, C., Ospina, B., & Cali, P. U. J. (2019) · Editorial Universidad Icesi eBooks · doi:10.18046/eui/iys.2.2019
Non-motor Symptoms of Parkinson’s Disease—Considerations for Subclinical and Atypical Seizures
Son, A. Y., Agarwal, S., Cucca, A., Sharma, K., & Biagioni, M. C. (2019) · touchREVIEWS in Neurology · doi:10.17925/usn.2019.15.2.91
Enhancing cognitive and functional assessment for Alzheimer’s disease
Козлова, И. А. (2019) · ERA
Disturbances of visual perception in non-demented patients with Parkinson’s disease
Timofejavaitė, R., Vilda, V., LIVEIKIENE, A., & Lokominienė, R. K. (2019) · Neurologijos seminarai · doi:10.29014/ns.2019.21
Cognitive tests that identify high risk of conversion to dementia in Parkinson’s diseasePreprint
Myall, D. J., Horne, K., MacAskill, M. R., Livingston, L., Pitcher, T. L., Melzer, T. R., Geurtsen, G. J., Anderson, T., & Dalrymple‐Alford, J. C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.31.126870
Kisvetrová, H. (2020) · doi:10.5507/fzv.20.24457086
Transcriptomic signatures associated with regional cortical thickness changes in Parkinson’s diseasePreprint
Keo, A., Dzyubachyk, O., van der Grond, J., van Hilten, J. J., Reinders, M. J. T., & Mahfouz, A. E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.19.158808
Garcia, P., Wemheuer, W. M., Huarte, O. U., Schmit, K. J., Masuch, A., Brioschi, S., Weihofen, A., Koncina, E., Coowar, D., Heurtaux, T., et al. (2020) · doi:10.21203/rs.3.rs-29977/v1
Tomše, P., Rus, T., Perovnik, M., Tang, C. C., Eidelberg, D., & Trošt, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815946-0.00019-3
Zhang, K., Wu, J., Jiang, W., Wang, Y., Rong, Z., Sun, L. Z., & Cheng, Y. X. (2020) · Research Square · doi:10.21203/rs.3.rs-126752/v1
Perspectives of Cognitive Impairment and Behavioral Disturbances in Parkinson’s Disease Dementia
Muñoz, B., Quintana-Peña, V., Alvarez, D., Valderrama, J., Takeuchi, Y., & Orozco, J. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96623
Valenzuela, C. S. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98773
Martínez-Serrato, Y., & Solís‐Vivanco, R. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2021.07.023
FUNCTIONAL NEUROMARKERS IN PARKINSON’S DISEASE (PD)
Góral-Półrola, J., Mirski, A., Knapik, H., & Pąchalska, M. (2021) · Acta Neuropsychologica · doi:10.5604/01.3001.0014.8146
Saleh, C., Meyer, A., Chaturvedi, M., Beltrani, S., Gschwandtner, U., & Fuhr, P. (2021) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000519053
Isasi, M. T. A., de la Prida, M. M., Lorenzo, J. V., Veiga, J. J., & Sánchez, J. L. (2021) · Neurología Argentina · doi:10.1016/j.neuarg.2021.07.007
Francisco llama a anunciar con alegría el evangelio
Ballester, M. G. (2013) · Teología Espiritual
Economic Development and Labour Structure in Malaysia in the 1990's
Yoshimura, M. (1998) · Institutional Repositories DataBase (IRDB) · doi:10.15002/00002141
Mihaylova, A., Doncheva, N., Zlatanova, H., Delev, D. P., & Kostadinov, I. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.10.513
Wang, J., Liu, J., Wang, Z., Gao, F., Yang, J., Wang, X.-C., Guo, Y., Wang, Y., Ma, B.-R., Wang, H.-S., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3997506
Human Nervous System Disorders
(2019) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-5225-8066-9.ch018
Yu, Y., Lv, J., Liu, J., Chen, Y., Chen, K., & Yang, Y.-F. (2022) · Research Square · doi:10.21203/rs.3.rs-1567017/v1
Cognitive improvement after dual-task training in Parkinson’s disease: a follow-up studyPreprint
Szögedi, D., Stone, T. W., Dinya, E., & Málly, J. (2022) · medRxiv · doi:10.1101/2022.04.27.22274290
What Cognition-Based Retinal Nerve Fiber Thickness Tells Us in Parkinson Disease?Preprint
Çekiç, S., Çınar, B. P., DEMİREL, E. A., Akdemir, M. O., Çelebi, U., Açıkgöz, M., & Atasoy, H. T. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4087723
Deep Brain Stimulation for Parkinson’s Disease
Kubu, C. S., Gostkowski, M., Rudolph, J., & Nagel, S. J. (2019) · Springer eBooks · doi:10.1007/978-1-4939-8722-1_18
Dillon, C., Leis, A., Castro, D. M., García, V., Zegarra, C., Leguizamon, P. P., Feldman, M. L., Laspiur, S. D., Viaggio, M. B., & Peralta, C. (2022) · Neurología Argentina · doi:10.1016/j.neuarg.2022.06.001 · Cited by 1
Liu, H., Deng, B., Wu, Z., Zhou, H., Chen, Y., Weng, G., Zhu, S., Xu, J., Wang, H., Zhou, Z., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4105597
Huang, M., Cai, X., Zhang, Y., Pu, W., Gao, B., & Yu, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1988963/v2
Szarpak, J., Drożak, P., Piwoński, M., Wróblewski, H., & Morylowska-Topolska, J. (2022) · Current Problems of Psychiatry · doi:10.2478/cpp-2022-0021
Domingues, V. L. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.39.2022.tde-23112022-165118
Guidelines for Therapeutic Management of Parkinson’s Disease in China
Lü, L., Chen, S., Yang, Y., Luo, Y., Xu, P., & Le, W. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_358
The growing evidence of neurodegenerative diseases risk factors
Ruiz‐Garcia, R. (2023) · Revista de Fomento Social · doi:10.24875/rmn.m22000093
Musich, M. L., Costa, A. N., Salathe, V., Miller, M. B., & Curtis, A. F. (2023) · Journal of Women s Health · doi:10.1089/jwh.2022.0462
Schulz, R., Uyar, M., Pérez, J. A. G., Pötter‐Nerger, M., Buhmann, C., Gerloff, C. P., & Choe, C. (2023) · medRxiv · doi:10.1101/2023.05.16.23290035
Learning of a postural control task in a virtual environment with Parkinson´s disease individuals
de Freitas, T. B., Bacha, J. M. R., Nuvolini, R. A., da Silva, K. G., Demers, M., Doná, F., Pompeu, J. E., & Torriani‐Pasin, C. (2023) · Brazilian Journal of Motor Behavior · doi:10.20338/bjmb.v17i1.316
The molecular neural mechanism underlying the acceleration of brain aging due to Dcf1 deficiency
Zhou, H., Wang, J., & Wen, T. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103884
On the application of Machine Learning and Complex Networks to Neuroscience
Alves, C. L. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.55.2023.tde-31082023-145944
Research trends in brain imaging of mild cognitive impairment in 25 years: a bibliometric analysis
Satyasari, D., & Rorong, A. T. W. (2023) · Universa Medicina · doi:10.18051/univmed.2023.v42.214-226
Yin, G., Hu, X., Xie, S., & Gong, D. (2023) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.spl.701
Beheshti, I., Perron, J., & Ko, J. H. (2023) · Research Square · doi:10.21203/rs.3.rs-3392867/v1
Untangling Cognitive Impairment in Parkinsonʼs Disease with Olfactory Testing and Neuroimagings
Baba, T. (2023) · Higher Brain Function Research · doi:10.2496/hbfr.43.207
Liu, R., & Cheng, W. (2023) · medRxiv · doi:10.1101/2023.11.06.23298189
Cognitive Dysfunction and Postoperative Cognitive Dysfunction — A System Review
Xue, B. (2023) · Journal of Innovations in Medical Research · doi:10.56397/jimr/2023.11.06
Gupta, V., & Prasad, S. (2024) · Research Square · doi:10.21203/rs.3.rs-3791127/v1
Correlato neurobiológico de los síntomas premotores del parkinson: el origen en la teoría de Braak
Villareal-Quiroz, V., Serna, C. F. B., Torres, Y. L. C., & Becerra-Hernández, L. V. (2024) · Medicina UPB · doi:10.18566/medupb.v43n1.a09
Investigating executive function disparities in mice with PD utilizing the 5-CSRT paradigmPreprint
Gu, H., Liao, Z., Zhou, Z., Liu, Z., Gu, M., Liang, X., Pan, H., & Tang, C. (2024) · Research Square · doi:10.21203/rs.3.rs-3888527/v1
Cano‐Villagrasa, A., López‐Zamora, M., Romero-Moreno, L., & González, B. V. (2024) · European Journal of Investigation in Health Psychology and Education · doi:10.3390/ejihpe14020026
Blood biomarker of Lewy body disease
平賀, 経., & 勝野, 雅. (2024) · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics · doi:10.3143/geriatrics.61.41
Lizio, R., Percio, C. D., Noce, G., Catania, V., Sorbera, V. T., Pandis, M. F. D., Rotondo, R., Ferri, R., Soricelli, A., Salvatore, M., et al. (2024) · Preprints.org · doi:10.20944/preprints202404.0939.v1
Gut-Brain Interplay and Cognitive Degeneration
Krishnamoorthy, K., Rajagopal, P., & Jayaraman, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-8803-7_4
Metadata
- Authors
- Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C.
- Affiliations
- King's College London (GB)
- Corresponding author
- Aarsland, Dag
- Venue
- Nature Reviews Neurology
- Published
- 2017-03-03
- Volume
- 13
- Issue
- 4
- Pages
- 217-231
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC5643027
- OpenAlex
- W2593272776
- Cited by
- 1,027
- References
- 216
- Citations by year
- 2026: 102 · 2025: 99 · 2024: 138 · 2023: 104 · 2022: 105 · 2021: 171 · 2020: 116 · 2019: 89 · 2018: 68 · 2017: 33
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Funders
- South London and Maudsley NHS Foundation Trust
- National Institute for Health and Care Research
- King's College London
- Institute of Psychiatry, Psychology and Neuroscience, King’s College London
- National Institute of Neurological Disorders and Stroke (P50NS053488)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Parkinson's disease, cognitive decline, Parkinson's disease dementia, mild cognitive impairment, cerebrospinal fluid biomarkers, amyloid-beta 42, Lewy body pathology, APOE ε4, GBA mutations, cognitive training, nootropic drugs
- MeSH terms
- Dementia, Humans, Parkinson Disease, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
